UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 43 filers reported holding UROGEN PHARMA LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $537,000 | -12.5% | 14,543 | +2.1% | 0.00% | -25.0% |
Q4 2018 | $614,000 | -19.9% | 14,250 | -12.3% | 0.00% | 0.0% |
Q3 2018 | $767,000 | +25.7% | 16,250 | +32.7% | 0.00% | +33.3% |
Q2 2018 | $610,000 | +0.2% | 12,250 | 0.0% | 0.00% | -25.0% |
Q1 2018 | $609,000 | +33.6% | 12,250 | 0.0% | 0.00% | +33.3% |
Q4 2017 | $456,000 | +18.1% | 12,250 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $386,000 | +74.7% | 12,250 | 0.0% | 0.00% | +50.0% |
Q2 2017 | $221,000 | – | 12,250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 789,297 | $37,278,000 | 70.39% |
Wildcat Capital Management, LLC | 375,479 | $17,734,000 | 13.68% |
Consonance Capital Management LP | 1,515,422 | $71,573,000 | 3.85% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $118,069,000 | 3.20% |
SHIKIAR ASSET MANAGEMENT INC | 78,425 | $3,704,000 | 1.44% |
MEITAV INVESTMENT HOUSE LTD | 584,104 | $27,799,000 | 1.36% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $15,676,000 | 0.72% |
Clal Insurance Enterprises Holdings Ltd | 310,000 | $14,641,000 | 0.39% |
DAFNA Capital Management LLC | 15,000 | $708,000 | 0.29% |
MOODY ALDRICH PARTNERS LLC | 18,200 | $860,000 | 0.25% |